Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | and quarterly through November 2027

Funding Amounts: Up to $250,000 direct costs per year (modular budget); maximum project period 5 years.

Summary: Supports innovative research in cancer control and population sciences, including statistical methods, epidemiology, survivorship, behaviors, healthcare delivery, digital health, and implementation science.

Key Information: Clinical trials are optional; foreign and domestic organizations are eligible; updated March 2025 to align with agency priorities.